Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.
A veterinary pharmaceutical company said they have received a conditional license for a bird flu vaccine to be used on ...
A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...
Since 2021, experts have seen bird flu — also called H5 influenza or highly pathogenic avian influenza (HPAI) — spreading ...
An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...
The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be ...
It is worth noting that AIM Vaccine previously disclosed in its performance announcements that the company is utilizing AI for tasks such as antigen structure design and mRNA sequence optimization.
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the ...
The Public Health Agency of Canada said Wednesday it's purchased 500,000 doses of a human vaccine to protect against avian ...
"When a new strain of HPAI was identified in the U.S. in early 2022, our scientists immediately began work to update our previous avian influenza vaccine," said Mahesh Kumar, Ph.D., senior vice ...
Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license ...